U.S.-Russian team announces breakthrough in fight against tuberculosis
A U.S.-Russian team has made a significant breakthrough in the fight against drug-resistant tuberculosis, with a new compound showing marked decreases in lung presence and symptoms. The SciClone Pharmaceuticals-Verta project is a milestone for scientific collaboration between U.S. industry and former Soviet researchers.